Emcure Pharmaceuticals IPO GMP: Namita Thapar to Benefit from Share Sale
Namita Thapar, the highly anticipated Emcure Pharmaceuticals IPO is set to commence tomorrow, Wednesday, July 3. This initial public offering is expected to generate approximately ₹127.87 crore for Namita Thapar, a prominent investor from Shark Tank India and a key member of the Emcure Pharmaceuticals promoter group. Namita Thapar, who acquired shares of Emcure Pharmaceuticals … Read more